Neogenomics (NEO) Non-Current Assets (2010 - 2026)

Neogenomics has reported Non-Current Assets for 17 years, with the latest figure at $972.8 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 5.32% year-over-year to $972.8 million; the trailing twelve-month figure through Mar 2026 stood at $972.8 million (down 5.32% YoY), and the FY2025 full-year result was $983.5 million, down 5.61% from the prior year.
• Non-Current Assets for Q1 2026 stood at $972.8 million, down from $983.5 million in the prior quarter.
• The five-year high for Non-Current Assets was $1.2 billion in Q1 2022, with the low at $972.8 million in Q1 2026.
• Historically, Non-Current Assets has averaged $1.1 billion across 5 years, with a median of $1.1 billion in 2024.
• Annual changes were most pronounced in 2022 — Non-Current Assets surged 113.61% — and 2025, when it decreased 5.61%.
• Neogenomics' Non-Current Assets stood at $1.1 billion in 2022, then fell by 4.44% to $1.1 billion in 2023, then fell by 3.91% to $1.0 billion in 2024, then retreated by 5.61% to $983.5 million in 2025, then dropped by 1.09% to $972.8 million in 2026.
• The last three Non-Current Assets figures came in at $972.8 million (Q1 2026), $983.5 million (Q4 2025), and $992.3 million (Q3 2025), per Business Quant data.